Erk pathway and activator protein 1 play crucial roles in FGF2‐stimulated premature cranial suture closure
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Cranial sutures are an important growth center of the cranial bones, and the suture space must be maintained to permit the cranial adjustments needed to accommodate brain growth. Craniosynostosis, characterized by premature suture closure, mainly results from mutations that generate constitutively active fibroblast growth factor (FGF) receptors. FGF signaling, thus, is responsible for the pathogenesis of craniosynostosis. Even though FGF activates many different signaling pathways, the one involved in premature suture closure has not been defined. We observed that placing FGF2‐soaked bead on the osteogenic fronts of cultured mouse calvaria accelerates cranial suture closure and strongly induces the expression of osteopontin, an early marker of differentiated osteoblasts. FGF2 treatment also induced fos and jun mRNAs and later increased the nuclear levels of activator protein 1 (AP1). FGF2 stimulates the expression of osteopontin by inducing expression of AP1, which then binds to its response element in the osteopontin promoter. Blocking of the Erk pathway by PD98059 suppressed the AP1 and osteopontin expression stimulated by FGF2. Coincidently, blocking of the Erk pathway also significantly retarded FGF2‐accelerated cranial suture closure. Thus, the Erk pathway mediates FGF/FGF receptor–stimulated cranial suture closure, probably by stimulating synthesis of AP1 that then stimulates the differentiation of osteoblasts. Developmental Dynamics 227:335–346, 2003. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whitmarsh, A. J., & Davis, R. J. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050063 · Cited by 1,543
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-269 · Cited by 614 · cited 2×
“Mutations in FGFRs causing CS render these receptors constitutively active (Muenke et al., 1994; Reardon et al., 1994).”
BackgroundDisruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation
Montero, A., Okada, Y., Tomita, M., Ito, M., Tsurukami, H., Nakamura, T., Doetschman, T., Coffin, J. D., & Hurley, M. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8641 · Cited by 483
Iseki, S., Wilkie, A. O. M., & Morriss-Kay, G. M. (1999) · Development · doi:10.1242/dev.126.24.5611 · Cited by 305
Breen, E. C., Ignotz, R. A., McCabe, L., Stein, J. L., Stein, G. S., & Lian, J. B. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041600214 · Cited by 138 · cited 1×
“Experiments where fos and jun expression in the bone was modulated by steroid hormone treatment or by overexpression or ablation of fos or jun genes suggest that the Fos and Jun proteins are important in the regulation of bone formation (Clohisy et al., 1992; Breen et al., 1994).”
Background
Cited by
Crane, N. J., Popescu, V., Morris, M. D., Steenhuis, P., & Ignelzi, M. A. (2006) · Bone · doi:10.1016/j.bone.2006.02.059 · Cited by 389
Wilkie, A. O. M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.03.001 · Cited by 255
Genetic advances in craniosynostosis
Lattanzi, W., Barba, M., Di Pietro, L., & Boyadjiev, S. A. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38159 · Cited by 129
“The common thread of the syndromes caused by perturbations of FGF signaling is the excessive activation of the downstream Ras/ MAPK pathway, with enhanced phosphorylation of Erk1/2 kinases (Kim et al., 2003; Park et al., 2012; Wang et al., 2012).”
BackgroundMT1-MMP Inactivates ADAM9 to Regulate FGFR2 Signaling and Calvarial Osteogenesis
Chan, K. M., Wong, H. L. X., Jin, G., Liu, B., Cao, R., Cao, Y., Lehti, K., Tryggvason, K., & Zhou, Z. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.04.014 · Cited by 83
Ueda, K., Yaoita, M., Niihori, T., Aoki, Y., & Okamoto, N. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38337 · Cited by 46
“Dysregulated cranial development derived from mutations in FGFR genes is partially mediated by genes whose products participate in the RAS/MAPK signaling pathway (Kim et al., 2003; Shukla, Coumoul, Wang, Kim, & Deng, 2007).”
Background
Metadata
- Authors
- Kim, H., Lee, M., Park, H., Park, M., Lee, S., Kim, S., Choi, J., Shin, H., Kim, H., & Ryoo, H.
- Venue
- Developmental Dynamics
- Publisher
- Wiley
- Published
- 2003-05-29
- Volume
- 227
- Issue
- 3
- Pages
- 335-346
- ISSN
- 1058-8388 (ISSN-L)
- 1097-0177
- OpenAlex
- W2059314014
- Cited by
- 72
- References
- 5
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Erk pathway and activator protein 1 play crucial roles in FGF2‐stimulated premature cranial suture closure. https://app.cochat.ai/papers/10.1002/dvdy.10319
- The paper
- Kim, H., Lee, M., Park, H., Park, M., Lee, S., Kim, S., Choi, J., Shin, H., Kim, H., & Ryoo, H. (2003). Erk pathway and activator protein 1 play crucial roles in FGF2‐stimulated premature cranial suture closure. Developmental Dynamics. https://doi.org/10.1002/dvdy.10319
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.